6-K - ATHE - Equibles

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM6-K

REPORTOF FOREIGN PRIVATE ISSUER

PURSUANTTO RULE 13a-16 OR 15d-163

UNDERTHE SECURITIES EXCHANGE ACT OF 1934

Forthe month of January 2025

AlterityTherapeutics Limited

(Name of Registrant)

Level 14, 350 Collins Street,Melbourne, Victoria 3000 Australia

(Address of Principal Executive Office)

Indicateby check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

ThisForm 6-K is being incorporated by reference into our Registration Statement on Form S-8 (Files No. 333-251073, 333-248980and 333-228671) and ourRegistration Statements on Form F-3 (Files No. 333-274816, 333-251647, 333-231417and 333-250076)

ALTERITYTHERAPEUTICS LIMITED

(adevelopment stage enterprise)

The following exhibits are submitted:

99.1	Application for quotation of securities

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Alterity Therapeutics Limited
By:	/s/ Geoffrey P. Kempler
	Geoffrey P. Kempler
	Chairman

Date: January 22, 2025

Exhibit 99.1

Appendix 2A - Application for quotation of securities

Announcement Summary

Entity name

ALTERITY THERAPEUTICS LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday January 22, 2025

The+securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security code	Security description	Number of +securities to be quoted	Issue date
ATH	ORDINARY FULLY PAID	95,238	22/01/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities	1/ 6
Appendix 2A - Application for quotation of securities
---

Part 1 - Entity and announcement details

1.1Name of entity

ALTERITY THERAPEUTICS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type	Registration number
ACN	080699065

1.3ASX issuer code

ATH

1.4The announcement is

New announcement

1.5Date of this announcement

22/1/2025

Appendix 2A - Application for quotation of securities	2/ 6
Appendix 2A - Application for quotation of securities
---

Part 2 - Type of Issue

2.1 The+securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX (“existing class”)

Appendix 2A - Application for quotation of securities	3/ 6
Appendix 2A - Application for quotation of securities
---

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securitiesin an existing class

FROM (Existing Class)

ASX +security code and description

ATHO : OPTION EXPIRING 31-AUG-2026

TO (Existing Class)

ASX +security code and description

ATH : ORDINARY FULLY PAID

Please state the number of options that were exercisedor other +convertible securities that were converted	The first date the options were exercised or other +convertible securities were converted	The last date the options were exercised or other +convertible securities were converted
95,238		20/1/2025

Is this all of the options or other +convertible securitieson issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

The right of the holder of the options or other +convertiblesecurities to receive the +underlying securities is being satisfied by:

An issue of new +securities

The underlying +securities being received by the holderare:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertiblesecurities being converted issued under an +employee incentive scheme?

Issue date

22/1/2025

Will the +securities to be quoted rank equally in allrespects from their issue date with the existing issued +securities in that class?

Yes ****

Appendix 2A - Application for quotation of securities	4/ 6
Appendix 2A - Application for quotation of securities
---

Issue details

Number of +securities to be quoted

95,238

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid?What is the issue price per +security?

AUD - Australian Dollar	AUD 0.01000000

Any otherinformation the entity wishes to provide about the +securities to be quoted

Appendix 2A - Application for quotation of securities	5/ 6
Appendix 2A - Application for quotation of securities
---

Part 4 - Issued capital following quotation

Following thequotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity’s current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities(total number of each +class of +securities quoted on ASX following the +quotation of the+securities subject of this application)

ASX +security code and description	Total number of +securities on issue
ATH : ORDINARY FULLY PAID		5,320,431,356
ATHO : OPTION EXPIRING 31-AUG-2026		932,611,430

4.2 Unquoted+securities (Total number of each +class of +securities issued but not quoted on ASX)

ASX +security code and description
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX 0.0375	14,250,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX 0.0238	11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX 0.09	35,000,000
ATHAAK : OPTION EXPIRING 30-DEC-2027 EX 0.01	170,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX 0.0105	8,000,000
ATHAB : OPTION EXPIRING 13-MAR-2029 EX US0.0031	62,500,000
ATHAA : OPTION EXPIRING 13-MAR-2029 EX 0.004	26,500,000
ATHAC : OPTION EXPIRING 21-MAR-2029 EX US0.003	120,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX 0.032	91,392,720

All values are in US Dollars.

Appendix 2A - Application for quotation of securities	6/ 6